Biotechnology BioMarin Receives Complete Response Letter (CRL) from FDA for Valoctocogene Roxaparvovec Gene Therapy for Severe Hemophilia A August 19, 2020
Biotechnology Alkermes Initiates Phase 2 Study Designed to Evaluate Clinical and Immunologic Activity of ALKS 4230 on Tumor Microenvironment in Patients with Advanced Solid Tumors August 19, 2020
Biotechnology China Biologic Reports Financial Results for the Second Quarter of 2020 August 17, 2020
Biotechnology Immunomedics Announces FDA Approval of Samsung Biologics as Antibody Manufacturer for Trodelvy(TM) August 17, 2020
Biotechnology Latest Clinical Research Evaluating VASCEPA® (Icosapent Ethyl) in Patients with Residual Cardiovascular Risk to be Presented at ESC Congress 2020, the Annual Meeting of the European Society of Cardiology August 17, 2020
Biotechnology American Journal of Psychiatry Publishes Data From Alkermes’ Phase 3 ENLIGHTEN-2 Weight Study of ALKS 3831 in Patients With Schizophrenia August 17, 2020
Biotechnology SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Reata Pharmaceuticals, Inc. - RETA August 16, 2020
Search
Biotechnology
August 14, 2020
